Karoli N A, Rebrov A P
Saratov State Medical University named after V.I. Razumovsky, Saratov, Russia.
Kardiologiia. 2017 Feb;57(2):83-90.
The article contains review of data on the problem of sudden cardiac death (SCD) in patients with chronic obstructive pulmonary disease (COPD). Large studies have shown that risk of cardiovascular mortality in patients with chronic obstructive pulmonary disease (COPD) is 2-3 times greater than in general population. The incidence of COPD and ischemic heart disease (IHD) progressively rises with age. Combination of these diseases is often observed in clinical practice among patients older than 40 years. According to the population study published in 2015 COPD has been associated with elevated risk of SCD especially in patients with frequent exacerbations within 5 years after diagnosis. SCD risk rises in patients with combination of COPD and cardiovascular diseases (myocardial infarction, hypertension, disturbances of cardiac rhythm), with severe clinical course, with frequent exacerbator phenotype. One of main factors underlying SCD is development of arrhythmia. According to 24-hour ECG monitoring supraventricular arrhythmias including atrial fibrillation prevail in COPD. Ventricular rhythm disturbances have been registered in patients with COPD mostly after large myocardial infarctions. Pathogenesis of arrhythmias in COPD if multifactorial. Targeted detection of comorbidities would allow to take into consideration individual characteristics while choosing pharmaotherapy. In patients with COPD and high SCD risk one should limit use of broncholytics especially short-acting, methylxanthines, drugs with potential to induce QT prolongation.
本文包含对慢性阻塞性肺疾病(COPD)患者心源性猝死(SCD)问题的数据综述。大型研究表明,慢性阻塞性肺疾病(COPD)患者的心血管死亡风险比普通人群高2至3倍。COPD和缺血性心脏病(IHD)的发病率随年龄增长而逐渐上升。在40岁以上的患者中,临床实践中经常观察到这两种疾病的合并情况。根据2015年发表的一项人群研究,COPD与SCD风险升高有关,尤其是在诊断后5年内频繁发作的患者中。COPD与心血管疾病(心肌梗死、高血压、心律紊乱)合并、临床病程严重、具有频繁加重型表型的患者,SCD风险会升高。SCD的主要潜在因素之一是心律失常的发生。根据24小时心电图监测,COPD患者中以包括房颤在内的室上性心律失常为主。COPD患者的室性心律紊乱大多在大面积心肌梗死后出现。COPD中心律失常的发病机制是多因素的。针对性地检测合并症将有助于在选择药物治疗时考虑个体特征。对于COPD且SCD风险高的患者,应限制使用支气管扩张剂,尤其是短效支气管扩张剂、甲基黄嘌呤以及有潜在导致QT间期延长作用的药物。